Clinical Trials
4 trialsNCT07087054 2026-04-30
CAREFNDR
Crinetics Pharmaceuticals Inc.
Phase 3 Recruiting
NCT00774930 2022-10-14
ELECT
Ipsen
Phase 3 Completed
NCT00092287 2020-04-30
Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome
Ipsen
Phase 3 Terminated
NCT04065165 2020-02-05
TELEFIRST
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Withdrawn